The place of conservation surgery for T3 laryngeal carcinomas with fixation.

Auris Nasus Larynx

Department of Otolaryngology, Istanbul Medical Faculty, University of Istanbul, Turkey.

Published: September 1992

Although the traditional surgical treatment of T3 laryngeal carcinomas is total laryngectomy, we have obtained favorable survival results for selected cases with partial laryngectomy, as exemplified in the literature. Extending the indications up to ultimate limits by partial, but radical surgical techniques is the recent trend in the world, for the conservation surgery of laryngeal cancers. The primary treatment of T3 laryngeal cancers, instead of irradiation, should be surgical and, for select cases partial laryngectomy, depending on laryngeal embryological development and lymphatic drainage, may be carried out. We have performed partial laryngectomy with elective or therapeutic and radical or modified radical neck dissection for 43 T3 laryngeal carcinomas at the Department of Otolaryngology, Istanbul Medical Faculty, University of Istanbul in the years 1978-1991 and obtained 2, 3, and 5 years of survival rates, which are 89, 79.4, and 73%, respectively.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0385-8146(12)80200-8DOI Listing

Publication Analysis

Top Keywords

laryngeal carcinomas
12
partial laryngectomy
12
conservation surgery
8
surgery laryngeal
8
treatment laryngeal
8
cases partial
8
laryngeal cancers
8
laryngeal
6
place conservation
4
carcinomas fixation
4

Similar Publications

Treatment strategy for intermediate-risk papillary thyroid cancer: Focus on postoperative hypothyroidism following lobectomy.

Auris Nasus Larynx

January 2025

Department of Otolaryngology Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, Okayama 700-8558, Japan.

Objective: An optimal surgical approach for intermediate-risk papillary thyroid cancer (PTC) has not yet been established. The surgical procedure should be determined based on treatment outcomes and postoperative complications. This study aimed to evaluate appropriate surgical strategies for patients with intermediate-risk PTC by comparing treatment outcomes and postoperative complications following total thyroidectomy and lobectomy.

View Article and Find Full Text PDF

Objective: To identify the most effective treatment modality for achieving favorable outcomes in early glottic tumors with anterior commissure involvement (ACI).

Data Sources: PubMed, Embase, Web of Science, and ScienceDirect.

Review Methods: Random-effects proportional meta-analysis model is used to evaluate the oncological and functional outcomes of transoral laser microsurgery (TLM) versus radiation therapy (RT) in early glottic (T1-T2) cancer with ACI.

View Article and Find Full Text PDF

To explore the operioperative and long-term outcomes of inflatable mediastinoscopic resection of esophageal carcinoma (IVMTE) and minimally invasive Mckeown resection of esophageal carcinoma (MIME) in early esophageal cancer. This is a retrospective cohort study. A retrospectively analysis was conducted on 176 patients with cT1N0M0 esophageal cancer who underwent IVMTE or MIME at the Department of Thoracic Surgery, Anhui Provincial Hospital Affiliated with Anhui Medical University from April 2017 to April 2019.

View Article and Find Full Text PDF

Functional and oncological outcomes of transoral laser versus robotic surgery in supraglottic squamous cell carcinoma.

Oral Oncol

January 2025

Department of Otolaryngology - Head & Neck Surgery Foch Hospital Suresnes France; School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), 2 Av. de la Source de la Bièvre 78 180 Montigny-le-Bretonneux, France; Phonetics and Phonology Laboratory (UMR 7018 CNRS & Université Sorbonne nouvelle), Paris, France.

Objective: To compare the surgical, functional and oncological outcomes of Transoral Laser Microsurgery (TLM) and Transoral Robotic Surgery (TORS) for the treatment of supraglottic squamous cell carcinoma.

Study Design: Retrospective case series with prospective data.

Settings: Tertiary Academic Medical Center.

View Article and Find Full Text PDF

Objective: Primary salivary gland squamous cell carcinoma (SCC) is extremely rare, accounting for 0.3-10.4 % of all salivary gland malignancies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!